The Kerala Story 2 has taken off at the ticket window with a huge jump on day 2 and hints at a roaring Sunday - BMS sales report.

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

GenerMotor is a pioneer in high-voltage DC (HVDC) power solutions, specializing in modular, stackable power generation technology designed for the AI and data center era. Collaborating with industry ...

At ELMIASOLAR 2026, Swatten showcased its complete portfolio of energy storage solutions, whose capabilities naturally align with Sweden’s rapidly evolving energy landscape. The lineup featured the ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with ...

Choosing the proper transmission-line topology can make or break channel-to-channel isolation when it comes to PCBs carrying ...

Amidst the controversial stay and release game, The Kerala Story 2 has managed to open low - day 1 box office report.

Expansion Led by Apple, Aligned Data Centers, AWS, CyrusOne, DataBank, and Digital Realty Lithium-ion batteries, with ...

What I can’t help commenting on is the incredible reply by Geroulanos, when a TV journalist (Papachlimintzos) asks him: “Mr. Geroulanos, you see that 68% of people in the polls are dissatisfied with ...